Patient Registry of Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO) by Japanese Experts
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Kurashiki Central Hospital
- Enrollment
- 19,000
- Locations
- 1
- Primary Endpoint
- successful revascularization without any major adverse cardiocerebral events (MACCE) at early follow-up and MACCE during the 5-year follow-up
Study Overview
Brief Summary
The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 20 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients eligible for PCI
- •Patients who underwent PCI for CTO lesions that contain the following:
- •Thrombolysis in myocardial infarction trial (TIMI) 0
- •The occlusive period more than 3 months or unknown
- •The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft
Exclusion Criteria
- •Patients ineligible for PCI judged in clinical practice
Outcomes
Primary Outcomes
successful revascularization without any major adverse cardiocerebral events (MACCE) at early follow-up and MACCE during the 5-year follow-up
Time Frame: within the first 1 month (plus 1 month) after PCI and during the 5-year follow-up
early and late results on major adverse cardiocerebral events (MACCE): all-cause death, coronary artery bypass grafting, re-PCI (target lesion revascularization/target vessel revascularization), admission for heart failure, myocardial infarction, admission for unstable angina, cerebrovascular disease, stent thrombosis in 19000 patients in and outside Japan
Secondary Outcomes
No secondary outcomes reported